Clinical Trials Browser

Phase 1/2 × OTHER × Hyperprolactinemia × Clear all

NCT03038308 2024-06-04

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

Phase 1/2 Completed

16 enrolled 8 charts

Hyperprolactinemia, Prolactinoma